Health Care & Life Sciences » Pharmaceuticals | FDC Ltd.

FDC Ltd. | Cash Flow

Fiscal year is April-March. All values INR Millions.
2014
2015
2016
2017
2018
Net Income before Extraordinaries
2,184
2,037
2,321
2,577
2,406
Depreciation, Depletion & Amortization
250
388
337
346
351
Other Funds
70
2
-
-
1,212
Funds from Operations
1,569
1,600
1,944
1,871
2,061
Changes in Working Capital
59
196
45
222
232
Net Operating Cash Flow
1,628
1,404
1,899
1,649
1,829
Capital Expenditures
1,512
1,750
3,197
261
370
Sale of Fixed Assets & Businesses
5
1,298
154
15
10
Purchase/Sale of Investments
586
569
2,156
1,293
230
Net Investing Cash Flow
770
1,018
887
1,539
130
Cash Dividends Paid - Total
400
468
963
-
482
Issuance/Reduction of Debt, Net
3
3
2
-
-
Net Financing Cash Flow
745
473
965
1
1,695
Net Change in Cash
113
87
45
105
10
Free Cash Flow
116
334
1,273
1,388
1,459
Other Sources
200
5
3
3
3
Change in Capital Stock
272
-
-
-
-
Exchange Rate Effect
-
-
2
4
5
Other Uses
50
3
3
3
3

About FDC

View Profile
Address
142-48, S. V. Road
Mumbai Maharashtra 400102
India
Employees -
Website http://www.fdcindia.com
Updated 09/14/2018
FDC Ltd. engages in the business of pharmaceutical. It presence in therapeutic segments, such as, anti-infectives, gastrointestinals, ophthalmologicals, vitamins, minerals, dietary supplements, cardiac, anti-diabetes, respiratory, gynaecology, dermatology, analgesics and others. The company products are sold under brand names, Electral, Enerzal, Vitcofol, Pyrimon, Zocon, Zoxan, Zathrin, Zipod, Zefu, Cotaryl and Mycoderm.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.